Full-Time
Hardware Engineering Manager
Posted on 7/11/2024
Synthego
201-500 employees
Provides synthetic RNA and gene editing tools
Compensation Overview
$160k - $190kAnnually
Expert
San Carlos, CA, USA
- B.S. in Mechanical Engineering or related field
- 10+ years of hands-on experience in life-sciences instrumentation and/or medical device development. At least 5 years in a managerial role
- Proven track record of delivery of instruments, automation systems and capital equipment in life-sciences, semiconductor or related fields
- Experience with the design and selection of fluidics, mechanisms, motion, robotics and thermal systems common to life-sciences instrumentation
- Proven track record of building and leading technical, cross-functional teams, particularly within a regulated environment
- Excellent verbal and written communications skills including presentation of technical content
- Willingness to provide mentorship and hands-on assistance in the lab
- Willingness to work in a startup environment and adapt to changing needs and priorities
- A driven outlook and with a strong desire to succeed
- Guide architectural level decisions on hardware projects and platforms
- Manage mechanical system and hardware development activities
- Work closely with other functional groups at Synthego
- Develop and maintain engineering processes and best practices
- Contribute to design reviews for subsystem and component level designs
- Manage procurement, organization and operations of a well-stocked CNC prototyping shop and hardware build lab
- Devise and implement strategies for continuous improvement of existing legacy equipment
- Perform conceptual, architectural and detailed mechanical design of novel instruments and instrument subsystems
- Mentor direct reports and potential new hires
Synthego specializes in biotechnology, focusing on genetic engineering by providing synthetic RNA and gene editing tools. Their products enable scientists to modify genes, which can lead to advancements in disease treatment and agricultural improvements. Synthego serves a variety of clients, including research institutions, pharmaceutical companies, and biotech startups, who utilize their products for drug discovery, disease modeling, and genetic research. The company stands out in the growing genetic engineering market by offering a platform that grants users access to advanced gene editing capabilities, alongside their synthetic RNA products. Synthego's goal is to support and enhance genetic research and applications through their tools and services.
Company Stage
Series E
Total Funding
$459.7M
Headquarters
Menlo Park, California
Founded
2012
6 month growth
↓ -28%1 year growth
↓ -37%2 year growth
↓ -54%
Simplify's Take
What believers are saying
- Synthego's licensing agreement with HuidaGene for the hfCas12Max nuclease positions it at the forefront of CRISPR-based therapeutic applications.
- The addition of Dr. Bill Skarnes to the advisory board and the launch of high-throughput induced pluripotent stem cell genome engineering highlight Synthego's commitment to innovation and expertise.
- The opening of a new GMP synthesis facility and the launch of IND-enabling gRNAs bolster Synthego's support for the entire discovery-to-clinic continuum, enhancing its market position.
What critics are saying
- The rapid pace of innovation in the genetic engineering field requires Synthego to continuously advance its technologies to stay competitive.
- Leadership changes, such as the recent CEO transition, could lead to strategic shifts and potential instability within the company.
What makes Synthego unique
- Synthego's focus on synthetic RNA and advanced gene editing tools, such as the high-fidelity Cas12 CRISPR nuclease, sets it apart from competitors who may not offer such specialized products.
- The company's strategic partnerships, like those with HuidaGene and bit.bio, enhance its capabilities in developing next-generation CRISPR-based therapies and synthetic circuitry in cells.
- Synthego's state-of-the-art GMP manufacturing facility ensures high-quality production of CRISPR components, providing a competitive edge in the clinical development of gene editing therapies.
Benefits
Generous Equity Package
Medical, Dental & Vision
401(k) Plan
Catered to You
Fully Stocked
Transportation
Green Environment
Stay Fit
Legal Ease